Company / Capital Expenditures
VYCOR MEDICAL INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$5.2K
FY2025
5-year range
$2.8K / $38.4K
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $2,780 in FY2022 to $183,258 in FY2017.
Based on SEC 10-K filings.
$5,224 in FY2025 with a 5-year CAGR of -39.0%.
Declined from $9,386 to $5,224 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +23.4%
- 5-Year CAGR
- -39.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -39.0%, indicating a declining trend.
- In FY2025, capital expenditures decreased 2.6% year-over-year.
- Peak capital expenditures was recorded in FY2017.
- Lowest capital expenditures in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2K | -2.6% |
| FY2024 | $5.4K | -42.8% |
| FY2023 | $9.4K | +237.6% |
| FY2022 | $2.8K | -92.8% |
| FY2021 | $38.4K | -38.2% |
| FY2020 | $62.1K | +17.3% |
| FY2019 | $52.9K | -16.7% |
| FY2018 | $63.5K | -65.3% |
| FY2017 | $183.3K | +219.0% |
| FY2016 | $57.5K | -56.1% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026